| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 1,250 | $30 | $32.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 300 | $90 | $27.3K |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | 120 | $180 | $21.2K |
| 45385 | The provider examines the colon and rectum using a colonoscope, a long, thin flexible tubular instrument with a light source and camera. He removes one or more tumors, polyps, or other lesions with a… | 70 | $210 | $14.6K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 130 | $120 | $14.6K |
| 45380 | The provider examines the rectum and colon using a flexible colonoscope, a tubular instrument with a light source and camera, to look for the cause of a patient's symptoms, which may include… | 90 | $140 | $13.3K |
| 43239 | The provider inserts a flexible endoscope through the mouth and down into the esophagus, stomach, and duodenum where he removes one or more tissue biopsy specimens for diagnostic analysis. | 120 | $90 | $10.4K |
| 91110 | The provider performs a capsule endoscopy for gastrointestinal tract imaging from esophagus to ileum. He interprets the results and prepares a report for this service. | 20 | $530 | $9.5K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 130 | $70 | $8.4K |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 50 | $180 | $8.3K |